DF/HCC Cancer Risk, Prevention, and Early Detection (CaRPED) Brief Updates Symposium

On an annual basis, the Dana Farber/Harvard Cancer Center Population Science Programs invite members to give an overview of the exciting scientific innovations and progress being made. The goal of this “Brief Updates” series is to share scientific advancements, facilitate active communication, build new collaborations, and show synergy across the Population Sciences programs.

Thursday, May 19, 2022

2:00-5:00 PM ET

What’s New in Cancer Risk, Prevention, and Early Detection (CaRPED) at DF/HCC
Virtual Symposium







Welcome and Introductions

Sapna Syngal, MD, MPH

Leader, CaRPED Program, DF/HCC


Keynote Address: Early Cancer Detection Strategies Using Ultrasensitive Protein Biomarkers

David R. Walt, Ph.D

Professor of Pathology, Brigham and Women’s Hospital

Hansjörg Wyss Professor of Biologically Inspired Engineering, Harvard Medical School

Core Faculty, Wyss Institute for Bioinspired Engineering, Harvard University

Howard Hughes Medical Institute Professor





CaRPED and Community Outreach



Moderator: Lecia Sequist, MD, MPH

Leader, CaRPED Program, DF/HCC



Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening (CARES) – A Stand Up To Cancer Dream Team

Jennifer Haas, MD, MSPH

Director, Center for Primary Care Research, Massachusetts General Hospital

Professor of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health

Professor of Medicine, Harvard Medical School


The Implementation Science Center for Cancer Control Equity (P50) – Making What We Know What We Do

Karen Emmons, PhD

Faculty Director, Community Engagement Program, Harvard Catalyst

Professor of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health



Q & A



CaRPED and Novel Diagnostics



Moderator: Gary Tearney, MD, PhD

Leader, CaRPED Program, DF/HCC



The MIDE study: A novel microRNA assay for early detection of ovarian cancer

Dipanjan Chowdhury, PhD

Chief, Division of Radiation and Genomic Stability, Dana-Farber Cancer Institute

Svanberg Family Chair, Dana-Farber Cancer Institute

Professor of Radiation Oncology, Harvard Medical School


Improving outcomes for patients with genitourinary malignancies through cfDNA analysis

Jacob Berchuck, MD

Medical Oncologist, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Instructor of Medicine, Harvard Medical School


Selected Abstract - Detection of circulating tumor human papillomavirus DNA years before diagnosis of HPV-positive head and neck cancer

Saskia Naegele

Research Scholar, Faden Lab, Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear


Q & A



Discussion with CaRPED Leaders about Future Grants and Collaborations 

Moderators: Giovanni Parmigiani, PhD and Lorelei Mucci, MPH, ScD

DF/HCC Population Science Programs Leaders

Lecia Sequist, MD, MPH, Sapna Syngal, MD, MPH, and Gary Tearney, MD, PhD

Leaders, CaRPED Program, DF/HCC


Click on the Zoom icon below to register or CLICK HERE
If you are having trouble logging into the meeting, please feel to contact us by clicking on the contact us tab.